Insights
In-depth regulation interpretation, authoritative policy insights shared by our experts and specialists.
Hot topic
Q&A
China CDE Q&A | Biologics' R&D, Associated Review of APIs, Excipients, and Packaging Materials, Requirements for Changes, and More
Sep 05, 2022
Q&A
China CDE Q&A | BE Study, Reference Listed Drug, and Quality & Therapeutic Equivalence Evaluation
Aug 30, 2022
INTERPRETATION
How to Submit Abbreviated New Drug Application (ANDA) for Generic Drugs in China
May 18, 2022
INTERPRETATION
How China Regulates Aesthetic Medicines—Thermage, Hyaluronic Acid, and Collagen
Oct 18, 2021